Table 1.
Baseline Characteristics of MI Patients (n=292)
| Age, yrs (SD) | 64.5 (14.6) |
| Male, n(%) | 184 (63) |
| Current smoker, n(%) | 74 (25) |
| Diabetes, n(%) | 64 (22) |
| Hypertension, n(%) | 186 (64) |
| Hyperlipidemia, n(%) | 194 (66) |
| Number of comorbidities, mean (SD) | 2.5 (1.8) |
| ST segment elevation myocardial infarction, n(%) | 86 (30) |
| Reperfusion, n(%) | 205 (70) |
| Cardiac rehabilitation enrollment, n(%) | 191 (65) |
| Medications at Discharge, n(%) | |
| Beta blockers | 248 (84) |
| ACE Inhibitors/ ARB | 180 (62) |
| Statins | 219 (75) |
SD= standard deviation; MI= myocardial infarction; ACE-I/ARB= angiotensin converting enzyme inhibitor/ angiotensin II receptor blocker